Simon Kindleysides, 34, from Norwich, was diagnosed with a brain tumour in 2013 which left him paralysed from the waist down.

Visual Domain Adaptation is a problem of immense importance in computer vision. Previous approaches showcase the inability of even deep neural networks to learn informative representations across domain shift. This problem is more severe for tasks where acquiring hand labeled data is extremely hard and tedious. In this work, we focus on adapting the representations learned by segmentation networks across synthetic and real domains. Contrary to previous approaches that use a simple adversarial objective or superpixel information to aid the process, we propose an approach based on Generative Adversarial Networks (GANs) that brings the embeddings closer in the learned feature space. To showcase the generality and scalability of our approach, we show that we can achieve state of the art results on two challenging scenarios of synthetic to real domain adaptation. Additional exploratory experiments show that our approach: (1) generalizes to unseen domains and (2) results in improved alignment of source and target distributions.

In the NIPS 2017 Learning to Run challenge, participants were tasked with building a controller for a musculoskeletal model to make it run as fast as possible through an obstacle course. Top participants were invited to describe their algorithms. In this work, we present eight solutions that used deep reinforcement learning approaches, based on algorithms such as Deep Deterministic Policy Gradient, Proximal Policy Optimization, and Trust Region Policy Optimization. Many solutions use similar relaxations and heuristics, such as reward shaping, frame skipping, discretization of the action space, symmetry, and policy blending. However, each of the eight teams implemented different modifications of the known algorithms.

The intersection between the fields of machine learning and quantum information processing is proving to be a fruitful field for the discovery of new quantum algorithms, which potentially offer an exponential speedup over their classical counterparts. However, many such algorithms require the ability to produce states proportional to vectors stored in quantum memory. Even given access to quantum databases which store exponentially long vectors, the construction of which is considered a one-off overhead, it has been argued that the cost of preparing such amplitude-encoded states may offset any exponential quantum advantage. Here we argue that specifically in the context of machine learning applications it suffices to prepare a state close to the ideal state only in the -norm, and that this can be achieved with only a constant number of memory queries. In recent years, machine learning has emerged as a rich area for showing quantum speedups [1-6], based in part on the seminal quantum algorithm of Harrow, Hassidim and Lloyd [7] for solving systems of linear equations.

Artificial intelligence (AI) can produce digital biomarkers of ageing and frailty by gathering physical activity data from smartphones and other wearables, scientists have found. The finding, published in the journal Scientific Reports, untaps the emerging potential of combining wearable sensors and AI technologies for continuous health risk monitoring with real-time feedback to life and health insurance, healthcare and wellness providers. "Artificial Intelligence is a powerful tool in pattern recognition and has demonstrated outstanding performance in visual object identification, speech recognition, and other fields," said Peter Fedichev from the Moscow Institute of Physics and Technology (MIPT) in Russia. "Recent promising examples in the field of medicine include neural networks showing cardiologist-level performance in detection of arrhythmia in ECG data, deriving biomarkers of age from clinical blood biochemistry, and predicting mortality based on electronic medical records," said Fedichev. The researches analysed physical activity records and clinical data from a large 2003-2006 US National Health and Nutrition Examination Survey (NHANES).

Thomas Metzinger had his first out-of-body experience when he was nineteen. He was on a ten-week meditation retreat in the Westerwald, a mountainous area near his home, in Frankfurt. After a long day of yoga and meditation, he had a slice of cake and fell asleep. Then he awoke, feeling an itch on his back. He tried to scratch it, but couldn't--his arm seemed paralyzed.

Key Target audience for Artificial Intelligence in retail is retail solutions, platforms, and service providers, AI system providers. IBM, Google, Microsoft, NVIDIA, Intel, and Amazon Web Services are some of the companies that provide AI in retail products and services. The key vendors profiled in the report are as follows such as IBM (US), Microsoft (US), Amazon Web Services (US), Oracle (US), SAP (Germany), Intel (US), NVIDIA (US), Google (US), Sentient technologies (US), Sales force (US), ViSenze (Singapore). North America is the highest contributor in the adoption and implementation of AI in retail. Artificial intelligence in retail market report provides detailed insights into the global AI in retail market to 2022. North America is expected to have the largest market size during the forecast period.

From eastern Europe to southern Iraq, the U.S. military faces a difficult problem: Adversaries pretending to be something they're not -- think Russia's "little green men" in Ukraine. But a new program from the Defense Advanced Research Projects Agency seeks to apply artificial intelligence to detect and understand how adversaries are using sneaky tactics to create chaos, undermine governments, spread foreign influence and sow discord. This activity, hostile action that falls short of -- but often precedes -- violence, is sometimes referred to as gray zone warfare, the'zone' being a sort of liminal state in between peace and war. The actors that work in it are difficult to identify and their aims hard to predict, by design. "We're looking at the problem from two perspectives: Trying to determine what the adversary is trying to do, his intent; and once we understand that or have a better understanding of it, then identify how he's going to carry out his plans -- what the timing will be, and what actors will be used," said DARPA program manager Fotis Barlos.

'#HumanTomorrow') is centered on technology, connected body or objects, ethics and DNA editing. A woman rides a cycle connected to an AI to propose a check-up. An aging global population, increased awareness of direct to consumer genetic testing and technological advances among others, put the genetics testing market at $10.3 billion by 2024. Tommi Lehtonen is the CEO of Blueprint Genetics based in Finland and San Francisco. The company, which provides genetic testing, has more than 100 employees and $19 M in equity to date from Finnish, German, Swiss and San Francisco-based venture capital companies.

On Thursday, Emmanuel Macron, the president of France, gave a speech laying out a new national strategy for artificial intelligence in his country. The French government will spend €1.5 billion ($1.85 billion) over five years to support research in the field, encourage startups, and collect data that can be used, and shared, by engineers. The goal is to start catching up to the US and China and to make sure the smartest minds in AI--hello Yann LeCun--choose Paris over Palo Alto. Directly after his talk, he gave an exclusive and extensive interview, entirely in English, to WIRED Editor-in-Chief Nicholas Thompson about the topic and why he has come to care so passionately about it. Nicholas Thompson: First off, thank you for letting me speak with you. It was refreshing to see a national leader talk about an issue like this in such depth and complexity. To get started, let me ask you an easy one. You and your team spoke to hundreds of people while preparing for this. What was the example of how AI works that struck you the most and that made you think, 'Ok, this is going to be really, really important'? Emmanuel Macron: Probably in healthcare--where you have this personalized and preventive medicine and treatment. We had some innovations that I saw several times in medicine to predict, via better analysis, the diseases you may have in the future and prevent them or better treat you.